Blood cell clones linked to age, ancestry and inflammation
An observational study detected these clones in 8.5% of each analysis cohort and in 4.0% of adults aged 18–39.
59,598 adults
Limit: Blood cell clones could raise inflammation, rather than inflammation driving clone growth
Edited by Boris Djordjevic · AgingResearch.News
An observational study analyzed DNA sequencing and health records from 59,598 adults in Mount Sinai’s multi-ancestry, hospital-based cohort. Researchers studied clonal hematopoiesis of indeterminate potential: the expansion of blood cell groups, or clones, carrying acquired mutations. After quality checks, they analyzed groups of 28,051 and 26,938 participants separately, then pooled results.
These clones became more common and larger with age across genetic ancestry groups. After accounting for age, participants of African ancestry had lower odds of the condition than those of European ancestry. Higher scores on a blood-based inflammation measure were associated with the condition after accounting for age, sex and ancestry. Having two different versions of one immune-system gene was associated with 7% lower odds of the condition.
Why it matters
The age-associated growth of blood cell clones raises questions about how immune differences and inflammation relate to changes in the blood across adulthood.
Caveats
This observational study cannot show that inflammation or inherited immune differences caused the blood cell changes. The hospital-based sample may not represent the general population, and the preprint has not been peer-reviewed.
The paper
Icahn School of Medicine at Mount Sinai
medRxiv, Oct 26, 2026, Open access, CC BY-NC-ND, Preprint, not peer-reviewed
